Cas:131875-08-6 Lexacalcitol manufacturer & supplier

Chemical Name:Lexacalcitol

CAS.NO:131875-08-6

Synonyms:(5Z,7E,20R)-20-((4-Ethyl-4-hydroxyhexyl)oxy)-9,10-secopregna-5,7,10(19)-triene-1a,3b-diol;LEVORPHANOL TARTRATE DIHYDRATE;(1S-(1a(S*),3ab,4E(1S*,3R*,5Z),7aa))-5-((1-(1-((4-Ethyl-4-hydroxyhexyl)oxy)ethyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-cyclohexanediol;LEVORPHANOL TARTRATE;L-3-HYDROXY-N-METHYLMORPHINAN;Lexacalcitol;LEVORPHANOL TARTRATE SALT;Levo-dromoran (tn);Levorphanol Tartrate CII (500 mg);Levorphanol Tartrate (CII),USP;1,3-Cyclohexanediol, 5-[(2E)-2-[(1S,3aS,7aS)-1-[(1R)-1-[(4-ethyl-4-hydroxyhexyl)oxy]ethyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1R,3S,5Z)-;(1S,3R,5Z,7E,9ξ,20R)-20-[(4-Ethyl-4-hydroxyhexyl)oxy]-9,10-secopregna-5,7,10-triene-1,3-diol;20-epi-22-oxa-24a,26a,27a-tri-homo-1,25-dihydoxyvitamin D3;(1S,3R,5Z,7E,9ξ,20R)-20-[(4-Ethyl-4-hydroxyhexyl)oxy]-9,10-secopregna-5,7,10-trien-1,3-diol;UNII:9G3DCA3958;levorphanol tartrate methanol solution;LEVORPHANOLTARTRATE,USP

Molecular Formula:C₂₉H₄₈O₄

Molecular Weight:460.689

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:600.3±55.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.542

PSA:69.92000

Exact Mass:460.355255

LogP:5.62

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (5Z,7E,20R)-20-((4-Ethyl-4-hydroxyhexyl)oxy)-9,10-secopregna-5,7,10(19)-triene-1a,3b-diol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,LEVORPHANOLTARTRATE,USP physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Levo-dromoran (tn) Use and application,(1S,3R,5Z,7E,9ξ,20R)-20-[(4-Ethyl-4-hydroxyhexyl)oxy]-9,10-secopregna-5,7,10-trien-1,3-diol technical grade,usp/ep/jp grade.

Related News: Results from a Phase I clinical trial, published in The Lancet, found that two-doses of the inhaled Ad5-nCoV vaccine can trigger a similar immune response to a single-dose of the injected version. Integrase (Human immunodeficiency virus type 1 isolate R101 gene polC-terminal fragment) manufacturers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” [(η(2,3)-C7H7CH2)Rh(η(5)-C5Me5)]PF6 suppliers However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. (R)-2-(3-(5-chlorothiophen-2-yl)ureido)-N-(3-methyl-4-(3-oxomorpholino)phenyl)pentanamide vendor & factory.